Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Cash & Current Investments (2019 - 2026)

Biodesix filings provide 8 years of Cash & Current Investments readings, the most recent being $25.6 million for Q1 2026.

  • On a quarterly basis, Cash & Current Investments rose 45.27% to $25.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $25.6 million, a 45.27% increase, with the full-year FY2025 number at $19.0 million, down 27.65% from a year prior.
  • Cash & Current Investments hit $25.6 million in Q1 2026 for Biodesix, up from $19.0 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $43.1 million in Q4 2022 to a low of $11.5 million in Q1 2024.
  • Median Cash & Current Investments over the past 5 years was $20.7 million (2025), compared with a mean of $23.4 million.
  • Biggest five-year swings in Cash & Current Investments: tumbled 70.36% in 2022 and later surged 142.51% in 2024.
  • Biodesix's Cash & Current Investments stood at $43.1 million in 2022, then crashed by 39.0% to $26.3 million in 2023, then decreased by 0.15% to $26.2 million in 2024, then dropped by 27.65% to $19.0 million in 2025, then soared by 34.68% to $25.6 million in 2026.
  • The last three reported values for Cash & Current Investments were $25.6 million (Q1 2026), $19.0 million (Q4 2025), and $16.6 million (Q3 2025) per Business Quant data.